戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d carriage of nonencapsulated S. pneumoniae (NESp).
2 d two oppositely imprinted genes, Gnasxl and Nesp.
3 ion-time curve was significantly greater for NESP (291.0 +/- 7.6 ng x h per ml versus 131.9 +/- 8.3 n
4   The volume of distribution was similar for NESP and Epoetin (52.4 +/- 2.0 ml/kg versus 48.7 +/-2.1
5                                              Nesp and Gnasxl represent oppositely imprinted promoters
6  the Nesp-Gnasxl-Gnas region was determined: Nesp and Gnasxl were found to be 15 kb apart, and Gnasxl
7 of the NESP55 and XLalphas promoter regions (Nesp and Gnasxl) is not established during gametogenesis
8 -regulation of Nespas and down-regulation of Nesp and Gnasxl.
9 temic infection resulted in encapsulation of NESp and increased virulence during bacteremia.
10                                 The upstream Nesp and Nespas/Gnasxl promoters are paternally and mate
11 ins closely juxtaposed maternally expressed (Nesp) and paternally expressed (Nespas, Gnasxl, Exon 1A)
12                          Remarkably, Gnasxl, Nesp, and Gnas are all part of the same transcription un
13 5 promoter region, the maternally methylated NESP antisense (NESPAS)/XLalphas promoter region and the
14 anscription unit; transcripts for Gnasxl and Nesp are alternatively spliced onto exon 2 of Gnas.
15                         We show that Epo and NESP are degraded only by cultured cells that express th
16                        Surface-bound Epo and NESP are internalized at the same rate (k(in) = 0.06 min
17 ion explains why Epo is degraded faster than NESP at the cellular level.
18 he novel erythropoiesis-stimulating protein (NESP) bring new options to allogeneic blood transfusion.
19 d the trafficking and degradation of Epo and NESP by EpoR-expressing cells.
20 acokinetics of an equivalent peptide mass of NESP by subcutaneous injection in six of these patients.
21                      These findings indicate NESp can compensate for lack of capsule production and r
22                We tested the hypothesis that NESp could acquire capsule during systemic infection and
23  associated with the trans-Golgi network and Nesp encodes a secreted protein of neuroendocrine tissue
24 ted transcripts were up-regulated, including Nesp, Gnasxl and Exon1A.
25       Imprinting of alternative transcripts, Nesp, Gnasxl and Nespas, in the cluster is unaffected.
26 ized into six transcriptional units, Nespas, Nesp, Gnasxl, F7, exon 1A, and Gnas.
27                      The organization of the Nesp-Gnasxl-Gnas region was determined: Nesp and Gnasxl
28 ed novel erythropoiesis-stimulating protein (NESP), has a lower affinity than Epo for the EpoR but ha
29                      The longer half-life of NESP is likely to confer a clinical advantage over Epoet
30 odes a paternal-specific transcript, whereas Nesp is paternally methylated with maternal-specific exp
31    Novel erythropoiesis stimulating protein (NESP) is a hyperglycosylated analogue of recombinant hum
32    Nonencapsulated Streptococcus pneumoniae (NESp) isolates increased among adults 18 to 64 years old
33           Epo binds surface EpoR faster than NESP (k(on) = 5.0 x 10(8) m(-1) min(-1) versus 1.1 x 10(
34                                         Some NESp lineages are associated with highly efficient DNA u
35 lation: paternal-specific methylation at the Nesp locus and maternal-specific methylation at the Gnas
36 inted transcripts in the mouse Gnas cluster (Nesp, Nespas, Gnasxl, Exon 1A and Gnas) provides a model
37 ethylate maternal imprint marks) showed that Nesp, Nespas/Gnasxl, and 1A imprinting depend on one or
38                        These mice had normal Nesp-Nespas/Gnasxl imprinting, indicating that the Gnas
39 ciated with the three genotypes based on the NESP:/NESPAS: sense/antisense and GNASXL: transcripts in
40                 Our kinetic model of Epo and NESP receptor binding, intracellular trafficking, and de
41                                     However, NESp strains lack capsule that may increase disease seve
42                               We reveal that NESp strains MNZ67 and MNZ41 are highly transformable an
43 The mean terminal half-life for subcutaneous NESP was 48.8 h.
44       The peak concentration of subcutaneous NESP was approximately 10% of that following intravenous
45  The mean terminal half-life for intravenous NESP was threefold longer than for intravenous Epoetin (
46 (100 U/kg) and an equivalent peptide mass of NESP were compared following intravenous bolus in 11 sta
47                    Natural transformation of NESp when co-administered with heat-killed encapsulated